Theravance (THRX) Higher After Compound Shows Clinical Significance

April 2, 2007 4:58 PM EDT Send to a Friend
Theravance, Inc. (Nasdaq: THRX) is 13% higher in after-hours trading after the company announced the results of two studies in ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login